By Emmanuel Bobby
Plans to quarantine Americans exposed to Ebola in Kenya have sparked mounting political, medical, and public backlash, with violent protests erupting in parts of the country and health experts in the United States warning that the proposal raises serious ethical and operational concerns.
The controversy intensified Tuesday after a Kenyan court extended an order temporarily blocking the establishment of a proposed quarantine center at Laikipia Air Base in central Kenya, while President William Ruto publicly defended the plan amid growing public anger and fears of a potential public health threat.
The proposed facility, backed by the United States and expected to accommodate up to 50 people, is intended to quarantine or treat Americans exposed to Ebola during aid missions or travel connected to the outbreak centered in the Democratic Republic of the Congo and neighboring Uganda.
The Trump administration has maintained that Americans exposed to Ebola should not be brought back to U.S. soil for treatment, marking a major shift from prior American outbreak responses and fueling heated debate among infectious disease specialists and policymakers.
The administration argues that treating potentially exposed Americans abroad would reduce the risks and logistical complexity of transporting patients to the United States during an escalating health emergency.
However, the proposal has provoked sharp criticism both inside Kenya and internationally.
President William Ruto defended the facility Tuesday, insisting that the project is part of Kenya’s long-term disease preparedness strategy and not an extraordinary or dangerous undertaking.
“The quarantine facility being established at Laikipia Air Base with the support of the United States is neither unique nor exceptional, but part of a broader national preparedness system,” Ruto said in a statement posted online.
He further sought to reassure citizens that the government understood the risks involved and had taken appropriate precautions.
“We are a responsible government. We know what we are doing,” Ruto said while speaking to reporters.
The Kenyan president emphasized that the initiative emerged from a longstanding partnership with Washington, describing it as part of broader cooperation between the two countries on public health and security matters.
According to Ruto, Kenya agreed to host the facility after a direct request from President Donald Trump, framing the decision as one rooted in diplomatic trust and decades of collaboration.
“When President Trump asked the government of Kenya to support them, I gave the OK because it was an agreement and a partnership with friends who have worked with Kenya for 30 to 40 years,” Ruto said.
Ruto also argued that the facility could strengthen Kenya’s own preparedness should Ebola spread more aggressively into East Africa.
The United States has reportedly committed approximately $13.5 million to support the partnership and the facility’s development.
But the funding commitment has done little to calm local outrage.
Residents in and around Nanyuki, the central Kenyan town near the proposed quarantine center, have voiced strong fears that hosting a treatment or quarantine site for Ebola-exposed individuals could increase the risk of infections and place surrounding communities in danger.
Large demonstrations reportedly intensified Monday, with angry crowds demanding that authorities abandon the project.
According to local reports, police deployed tear gas to disperse demonstrators as tensions escalated.
A protest organizer told international media that at least two people died after police allegedly opened fire during confrontations with demonstrators, though police officials and local health authorities had not independently confirmed those reports as of Tuesday.
The unrest prompted legal intervention.
A Kenyan High Court judge issued an order barring authorities from proceeding with construction or operational planning at the Laikipia facility pending resolution of a court challenge brought against the government.
The ruling effectively pauses implementation of the quarantine plan and adds legal uncertainty to a proposal already facing fierce resistance.
The controversy comes amid worsening concern over the growing Ebola outbreak in Central and East Africa.
The World Health Organization said last week that the outbreak of the rare Bundibugyo strain of Ebola had resulted in hundreds of suspected cases and deaths after spreading from eastern Congo into neighboring Uganda.
Unlike some other Ebola strains, there is currently no approved vaccine or known treatment for Bundibugyo Ebola, heightening anxiety among health authorities attempting to contain its spread.
Updated figures released Tuesday showed a shifting epidemiological picture.
According to WHO officials, there have been 321 confirmed cases in Congo along with 116 suspected infections, with many earlier suspected cases ruled out after further investigations.
Health officials said 48 deaths and six recoveries had been confirmed in Congo.
In Uganda, authorities initially reported nine confirmed cases and one death linked to the outbreak, though the country’s Health Ministry later announced six additional infections, bringing Uganda’s confirmed total to 15.
The Trump administration has insisted that infected individuals or exposed Americans should not enter the United States under any circumstances.
Officials have said the government “cannot and will not allow” Ebola cases into the country, a position that marks a notable departure from the U.S. response to the 2014 Ebola outbreak, when infected American medical workers and aid personnel were transported back to highly specialized treatment centers in the United States.
That change in policy has alarmed many public health professionals.
In an open letter sent to Congress, several American medical experts criticized the proposed overseas quarantine strategy and warned that abandoning domestic treatment capabilities could undermine outbreak management and create dangerous precedents.
The letter described the policy as raising “profound clinical, ethical, operational, and legal concerns.”
The signatories — including infectious disease specialists, emergency physicians, epidemiologists, and former public health officials — argued that the United States already possesses some of the world’s most advanced biocontainment and infectious disease facilities designed specifically for managing dangerous pathogens like Ebola.
“These centers were built for situations exactly like this,” the group argued, warning that shifting treatment abroad could complicate medical care, reduce oversight, and strain already overburdened outbreak response systems.
“At a time when outbreak response efforts are already strained, this is a dangerous precedent,” the experts wrote.
The White House has defended the proposed Kenya-based quarantine center, arguing that treatment closer to outbreak zones could accelerate care and eliminate delays associated with complex medical evacuations.
Administration officials say the facility would allow exposed Americans to receive immediate monitoring and treatment while reducing logistical challenges and preventing possible risks associated with international transport.
As of Tuesday, however, the White House had not publicly responded to criticism from health experts, legal challenges in Kenya, or reports of fatalities linked to anti-facility protests.
With court proceedings ongoing and tensions rising on the streets, the future of the U.S.-backed quarantine center remains uncertain, even as Ebola cases continue to spread and governments race to contain one of the region’s most concerning disease outbreaks in years.